References
- Barker AF. Bronchiectasis. N Engl J Med. 2002;346(18):1383–1393. DOI:https://doi.org/10.1056/NEJMra012519
- King PT, Holdsworth SR, Freezer NJ, et al. Outcome in adult bronchiectasis. COPD. 2005;2(1):27–34. DOI:https://doi.org/10.1081/copd-200050685
- Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138(4):944–949. DOI:https://doi.org/10.1378/chest.10-0099
- Ringshausen FC, de Roux A, Pletz MW, et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8(8):e71109. DOI:https://doi.org/10.1371/journal.pone.0071109
- Sánchez-Muñoz G, López de Andrés A, Jiménez-García R, et al. Time trends in hospital admissions for bronchiectasis: analysis of the Spanish national hospital discharge data (2004 to 2013). PLoS One. 2016;11(9):e0162282. DOI:https://doi.org/10.1371/journal.pone.0162282
- Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, et al. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20(1):11–23. DOI:https://doi.org/10.5588/ijtld.15.0472
- Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):7–16. DOI:https://doi.org/10.1016/j.ccm.2013.10.002
- Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. DOI:https://doi.org/10.1183/09031936.06.00124605
- Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57(1):61–69. DOI:https://doi.org/10.1016/j.arbr.2020.07.017
- López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:https://doi.org/10.1111/resp.12660
- Dang-Tan T, Ismaila A, Zhang S, et al. Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review. BMC Res Notes. 2015;8:464. DOI:https://doi.org/10.1186/s13104-015-1427-y
- Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465–1475. DOI:https://doi.org/10.2147/COPD.S83910
- Du Q, Jin J, Liu X, et al. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150532. DOI:https://doi.org/10.1371/journal.pone.0150532
- O’Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000; 55(8):635–642.
- Goeminne PC, Hernandez F, Diel R, et al. The economic burden of bronchiectasis - known and unknown: a systematic review. BMC Pulm Med. 2019;19(1):54. DOI:https://doi.org/10.1186/s12890-019-0818-6
- Explotación estadística del Conjunto Mínimo Básico de Datos Hospitalarios Nota Metodológica - NORMA ESTATAL [Internet]. [cited 2019 apr 14]. available at http://www.mscbs.gob.es/estadEstudios/estadisticas/docs/NORMAGRD2011/norma_estatal_2011_notas_metod.pdf.
- Instituto Nacional de Estadística (INE). [Internet]. [cited 2019 April 14]. available at http://www.ine.es.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. DOI:https://doi.org/10.1016/0895-4356(92)90133-8
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. DOI:https://doi.org/10.1016/0021-9681(87)90171-8
- Sánchez-Muñoz G, Lopez-de-Andrés A, Hernández-Barrera V, et al. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender. PLoS One. 2019;14(1):e0211222. DOI:https://doi.org/10.1371/journal.pone.0211222
- Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186–193. DOI:https://doi.org/10.1183/13993003.01033-2015
- De la Rosa D, Martínez-Garcia MA, Olveira C, et al. Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence. Chron Respir Dis. 2016;13(4):361–371. DOI:https://doi.org/10.1177/1479972316643698
- Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. DOI:https://doi.org/10.1164/rccm.201208-1518OC
- Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11(6):605–614. DOI:https://doi.org/10.3109/15412555.2014.922174
- Garcia Vidal C, Almagro P, Romani V, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbations: a prospective study. Eur Respir J. 2009;34(5):1072–1078. DOI:https://doi.org/10.1183/09031936.00003309
- Chung WS, Lin CL. Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study. Respir Med. 2018;140:6–10. DOI:https://doi.org/10.1016/j.rmed.2018.05.008
- Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411. DOI:https://doi.org/10.2147/COPD.S132961
- Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest. 2015;147(4):989–998. DOI:https://doi.org/10.1378/chest.14-2146
- Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. DOI:https://doi.org/10.1080/15412555.2016.1199669
- De Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–723. DOI:https://doi.org/10.1016/j.rmed.2013.01.007
- Seifer FD, Hansen G, Weycker D. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice. Chron Respir Dis. 2019;16:1479973119839961. DOI:https://doi.org/10.1177/1479973119839961
- Portal Estadístico. Área de inteligencia de gestión [internet]. [cited 2019. April 14]. available at https://pestadistico.inteligenciadegestion.mscbs.es/publicoSNS/S.
- De la Rosa Carrillo D, Navarro Rolon A, Girón Moreno RM, et al. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis. Respiration. 2018;96(5):406–416. DOI:https://doi.org/10.1159/000489935
- Seitz AE, Olivier KN, Adjemian J, et al. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432–439. DOI:https://doi.org/10.1378/chest.11-2209
- Ringshausen FC, de Roux A, Diel R, et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46(6):1805–1807. DOI:https://doi.org/10.1183/13993003.00954-2015
- Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205–209. DOI:https://doi.org/10.1097/01.cpm.0000171422.98696.ed